News

Management of Lymphoma Associated with Sjögren's Syndrome

Publish date: April 24, 2012

 

EXPERT ANALYSIS FROM A RHEUMATOLOGY MEETING SPONSORED BY NEW YORK UNIVERSITY

Dr. Carsons reported no relevant financial relationships.

Pages

Recommended Reading

FDA Panel: Update Bisphosphonate Labeling
MDedge Hematology and Oncology
HPV Vaccine Safe, Effective in Girls with JIA
MDedge Hematology and Oncology
FDA Steps Up Cancer Surveillance of TNF Blockers
MDedge Hematology and Oncology
FDA Advises Caution When IV Methotrexate-PPI Used Together
MDedge Hematology and Oncology
Breast Cancer Drug Exemestane Linked to BMD Loss
MDedge Hematology and Oncology
FDA Issues Guidelines on Developing Biosimilar Products
MDedge Hematology and Oncology
JIA Cancer Rates Not Linked to Medication
MDedge Hematology and Oncology
Side Effects Challenge Opioid Therapy for Acute Pain
MDedge Hematology and Oncology
FDA: Continue Study of Antinerve Growth Factors for Pain
MDedge Hematology and Oncology
Late Oral Complications After Head/Neck Radiation 'Underreported'
MDedge Hematology and Oncology